Klein D N, Schatzberg A F, McCullough J P, Keller M B, Dowling F, Goodman D, Howland R H, Markowitz J C, Smith C, Miceli R, Harrison W M
Department of Psychology, State University of New York at Stony Brook, 11794-2500, USA.
J Affect Disord. 1999 Jan-Mar;52(1-3):187-96. doi: 10.1016/s0165-0327(98)00079-2.
This study examined the validity of the early-late onset subtyping distinction in dysthymic disorder.
Participants were 340 out-patients meeting DSM-III-R criteria for dysthymia and a concurrent major depressive episode (MDE). The sample was drawn from a 12-site double-blind randomized parallel group trial comparing the efficacy of sertraline and imipramine in the treatment of chronic depression. All patients received comprehensive evaluations using semi-structured interviews and rating scales.
73% of the sample met criteria for the early-onset, and 27% for the late-onset, subtype. The early-onset patients had a significantly longer index MDE, significantly higher rates of personality disorders and lifetime substance use disorders, and a significantly greater proportion had a family history of mood disorder. The subgroups did not differ in symptom severity or functional impairment at baseline, nor in response to a 12-week trial of antidepressants.
Further work is needed to extend these findings to dysthymic disorder without superimposed MDEs.
These results support the distinction between early-onset and late-onset dysthymic disorder.
本研究检验了心境恶劣障碍中早发型与晚发型亚型区分的有效性。
参与者为340名符合DSM-III-R心境恶劣障碍及并发重度抑郁发作(MDE)标准的门诊患者。样本取自一项比较舍曲林和丙咪嗪治疗慢性抑郁症疗效的12中心双盲随机平行组试验。所有患者均通过半结构化访谈和评定量表接受全面评估。
73%的样本符合早发型亚型标准,27%符合晚发型亚型标准。早发型患者的首发MDE持续时间显著更长,人格障碍和终生物质使用障碍的发生率显著更高,且有心境障碍家族史的比例显著更大。两组在基线时的症状严重程度或功能损害方面无差异,对抗抑郁药12周试验的反应也无差异。
需要进一步开展工作,将这些发现扩展至无叠加MDE的心境恶劣障碍。
这些结果支持早发型与晚发型心境恶劣障碍的区分。